--:--:-- UTCVianordis / ED. 02 / 2026
Register reviewed 6 August 2026
Known limitations.
Public product and managed-service limitations that affect current evaluation and deployment scope. Security vulnerabilities use the private reporting process and are not published here.
| ID | Component | Limitation | Severity | Workaround | Planned resolution |
|---|---|---|---|---|---|
| LIM-001 | Vianordis Core | External installation, upgrade, and recovery have not completed independent validation. | High | Use invitation-based managed validation only. | Complete external installation and recovery gate |
| LIM-002 | All applications | Public source, supported-version matrices, and self-hosting documentation are not yet available. | High | Use only the managed scope expressly listed in an order. | Publish progressively after application gates |
| LIM-003 | Managed service | No production availability SLA applies to Controlled Beta or Alpha components. | High | Use validation response targets in a signed order. | Define production-ready service scope before offering an SLA |
| LIM-004 | Regions and recovery | Replication, RPO, RTO, backup, and recovery exercise results are not universal across services. | High | Use the service-specific schedule and documented exclusions. | Publish tested scope and recovery evidence per service |
| LIM-005 | Velum HYOK | Supported data domains, proxy placement, visible metadata, failure behaviour, and backup scope require tenant-specific validation. | Medium | Complete a domain and architecture review before use. | Publish validated HYOK domain profiles |
| LIM-006 | Documentation | Quickstart, API, upgrade, recovery, and contribution documentation remain incomplete. | Medium | Use available product, release, trust, and limitation pages. | Publish documents as their gates pass |
| LIM-007 | Omniscola | Controlled Alpha; no general availability and no consequential admissions, grading, assessment, or proctoring decisions. | High | Use synthetic data and a signed design-partner scope. | Strong Beta and accepted education PoC |
| LIM-008 | Aether | Controlled Alpha; no unrestricted clinical use or automated clinical decisions. | High | Use synthetic data and controlled human-supervised validation. | Strong Beta and accepted healthcare PoC |
| LIM-009 | Product demonstration | The public interactive demonstration is scripted and uses synthetic data; a recorded run of an actual application build is not yet published or scheduled. | Medium | Request a controlled live demonstration during managed-access review. | Record and publish an unedited, build-labelled workflow demonstration after the validation build is stable |
| LIM-010 | Production contracting | The public website does not claim that the full first-customer production contract pack or a production-ready service has passed final internal approval. | High | Use signed Beta or design-partner terms only; verify every applicable contract schedule before commitment. | Complete legal, security, support, recovery, processor, exit, and production-readiness gates before the first production order |